The risk of symptomatic COVID-19 was 14.7% in the BCG group and 12.3% in the placebo group during the first 6 months of the trial.
Study: TB vaccine ineffective against COVID-19
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Caregiver stress lessened after pandemic lockdowns lifted, study finds
- Dip in alcohol consumption in early pandemic linked to less social drinking
- High-risk patients with COVID symptoms should use PCR rather than rapid tests, study suggests
- Peer support valuable intervention for health worker stress during COVID-19, study shows